A new clinical trial called DIANA is testing whether combining supervised exercise, psychological counseling, and nutrition support during breast cancer chemotherapy can improve treatment effectiveness. Researchers predict this multimodal approach could increase favorable treatment responses from 40% to 60%, a 20 percentage point improvement, while also reducing side effects and improving quality of life during cancer treatment.

Researchers are testing whether combining exercise, therapy, and nutrition advice during breast cancer chemotherapy could help the treatment work more effectively. The DIANA trial will follow 216 women with early-stage breast cancer, with half receiving standard care and half receiving a personalized program of supervised exercise, psychological support, and nutritional guidance throughout their chemotherapy. According to Gram Research analysis, scientists hope this combined approach might increase the rate of favorable treatment responses by 20 percentage points, from 40% to 60%, while also improving quality of life and recovery. The study will track participants for at least 5 years to see if these lifestyle changes produce lasting benefits.

Key Statistics

The DIANA randomized controlled trial, enrolling 216 women with early-stage breast cancer in 2024, predicts that multimodal prehabilitation combining exercise, psychotherapy, and nutritional support could increase favorable pathological response rates from 40% to 60% during neoadjuvant chemotherapy.

According to the DIANA trial protocol published in 2026, researchers expect the intervention group to show improved chemotherapy tolerance, faster postoperative recovery, and better quality of life compared to standard care alone across 4 to 6 months of treatment.

The DIANA study plans to follow 216 breast cancer patients for a minimum of 5 years, with potential extension to 10 years, to determine whether lifestyle interventions during chemotherapy produce lasting improvements in recurrence rates and overall survival.

The Quick Take

  • What they studied: Whether adding exercise, therapy, and nutrition support during breast cancer chemotherapy helps the treatment work better and improves how patients feel and recover.
  • Who participated: 216 women with early-stage breast cancer who are receiving chemotherapy before surgery. Half will get standard care, and half will get the special program combining exercise, counseling, and nutrition advice.
  • Key finding: Researchers predict that women in the intervention group will have a 20 percentage point higher rate of favorable treatment response (60% versus 40%), meaning more cancer cells will be destroyed by chemotherapy.
  • What it means for you: If this trial succeeds, breast cancer patients might have a simple, non-invasive way to boost their treatment effectiveness while feeling better during chemotherapy. However, these are predictions based on a new study, so results need to be confirmed before changing standard care.

The Research Details

The DIANA trial is a randomized controlled trial, which is one of the strongest ways to test whether a treatment works. Researchers will divide 216 women into two equal groups: one receiving standard chemotherapy care, and one receiving the same chemotherapy plus a special multimodal prehabilitation program. The word prehabilitation means preparing the body and mind before a major medical event.

The intervention group will participate in a personalized program lasting 4 to 6 months during their chemotherapy. This program includes three main components: supervised physical exercise tailored to each person’s fitness level, psychotherapy or counseling to support mental health, and nutritional counseling to optimize diet. All three components happen together, which is why it’s called multimodal, meaning multiple approaches combined.

Researchers will measure how well the cancer responds to treatment using something called the Residual Cancer Burden index, or RCB. This measures how much cancer remains after chemotherapy but before surgery. They’ll also track quality of life, recovery speed, and how well patients tolerate the chemotherapy drugs.

This research design is important because it tests a real-world question: can lifestyle changes during cancer treatment actually improve how well the treatment works? Previous studies show that lifestyle factors matter for cancer prevention and long-term survival, but few studies have tested whether they can improve the immediate response to chemotherapy. By combining exercise, mental health support, and nutrition all at once, researchers can see if this comprehensive approach is more powerful than any single intervention alone.

This is a well-designed study with several strengths. It’s a randomized controlled trial, which means participants are randomly assigned to groups, reducing bias. The study has a clear primary outcome (favorable RCB response), a reasonable sample size of 216 participants, and long-term follow-up planned for at least 5 years. The protocol was approved by an ethics committee before starting. However, this is a protocol paper describing the planned study, not the results yet, so we don’t know if the predictions will come true. Results won’t be available until the trial is completed.

What the Results Show

This paper presents the study plan, not the actual results, since the trial is still ongoing. However, the researchers have made specific predictions based on existing evidence. They predict that 60% of women in the intervention group will achieve a favorable pathological response (meaning most cancer cells are destroyed), compared to 40% in the standard care group. This would represent a 20 percentage point improvement, which would be clinically meaningful.

The researchers expect additional benefits beyond improved cancer response. They anticipate that women in the intervention group will tolerate chemotherapy better, meaning fewer severe side effects and better ability to complete all planned treatments. They also expect improved quality of life during treatment, faster recovery after surgery, and better overall physical fitness, mental health, and nutritional status.

The study will also examine differences in the tumor microenvironment, which refers to the cells and substances surrounding the cancer. Some research suggests that exercise and stress reduction might change this environment in ways that make chemotherapy more effective.

Beyond the main cancer response measure, researchers will track several other important outcomes. These include how well patients tolerate chemotherapy (fewer hospitalizations and dose reductions), quality of life scores, physical fitness improvements, psychological well-being, nutritional status, and speed of postoperative recovery. The study will also measure long-term oncological outcomes, meaning whether the intervention affects recurrence rates and overall survival over 5 to 10 years of follow-up.

This trial builds on existing research showing that lifestyle factors influence cancer risk and survival. Previous studies have demonstrated that exercise reduces cancer risk, improves survival in some cancer types, and reduces chemotherapy side effects. Psychological support has been shown to improve quality of life and may reduce stress-related immune suppression. Nutritional optimization can improve treatment tolerance. However, few studies have tested whether combining all three approaches during active chemotherapy can actually improve how well the treatment destroys cancer cells. This trial aims to fill that gap.

Since this is a protocol paper rather than results, the main limitation is that we don’t yet know if the predictions will come true. Once results are available, potential limitations may include difficulty getting all participants to complete the full intervention program, differences in how well participants follow exercise and nutrition recommendations, and the possibility that results may differ in different populations or healthcare settings. The study focuses on early-stage breast cancer, so results may not apply to advanced cancer. Additionally, the intervention requires significant resources and personalized supervision, which may not be available everywhere.

The Bottom Line

This is a promising research direction, but recommendations cannot be made until the trial is completed and results are published. Women currently undergoing chemotherapy for early-stage breast cancer should discuss with their oncology team whether participating in exercise, counseling, or nutrition programs might be appropriate for them. Standard care should not be delayed or changed based on this protocol alone. Once results are available, they may support adding these supportive interventions to standard cancer treatment.

This research is most relevant to women with early-stage breast cancer who are receiving chemotherapy before surgery. It may also interest cancer care providers, oncologists, and healthcare systems looking for ways to improve treatment outcomes. Family members and caregivers of breast cancer patients may also find this relevant. The findings would be less applicable to people with advanced cancer or other cancer types until further research is done.

The DIANA trial is expected to take several years to complete. Researchers plan to follow participants for at least 5 years after treatment, with potential extension to 10 years. Results from the primary analysis (comparing cancer response between groups) may be available within 2 to 3 years, but long-term outcome data will take longer. Patients should not expect immediate changes to standard care based on this protocol.

Frequently Asked Questions

Can exercise during chemotherapy help cancer treatment work better?

The DIANA trial is testing this question. Researchers predict that supervised exercise combined with counseling and nutrition support could increase favorable treatment responses from 40% to 60% in early-stage breast cancer patients receiving chemotherapy. Results aren’t available yet, but existing research suggests exercise improves treatment tolerance and side effects.

Is it safe to exercise while getting chemotherapy for breast cancer?

The DIANA trial uses supervised, individualized exercise programs designed specifically for people undergoing chemotherapy. Always discuss exercise plans with your oncology team first. They can recommend safe activities based on your specific situation, fitness level, and side effects. Supervised programs are generally safer than unsupervised exercise.

How long does the DIANA breast cancer study last?

The intervention program lasts 4 to 6 months during chemotherapy. However, researchers will follow participants for at least 5 years after treatment ends, with plans to extend follow-up to 10 years. This long-term tracking helps determine whether lifestyle changes produce lasting benefits for cancer recurrence and survival.

What is residual cancer burden and why does it matter?

Residual cancer burden, or RCB, measures how much cancer remains after chemotherapy but before surgery. Lower RCB indicates better treatment response. The DIANA trial uses RCB to measure whether the combined intervention helps chemotherapy destroy more cancer cells. Better pathological response often predicts better long-term outcomes.

Who can participate in the DIANA breast cancer trial?

The DIANA trial enrolls women with early-stage breast cancer who are receiving chemotherapy before surgery. Specific eligibility criteria are listed on ClinicalTrials.gov under trial number NCT07107594. If you’re interested in participating, discuss it with your oncology team or visit the trial website for enrollment information.

Want to Apply This Research?

  • Track weekly exercise minutes (target 150 minutes moderate activity), mood scores on a 1-10 scale, and daily nutrition adherence (servings of fruits, vegetables, and protein). Log these metrics alongside chemotherapy cycle dates to correlate lifestyle factors with treatment tolerance and side effects.
  • Start with one small change: commit to 10 minutes of daily movement (walking, gentle stretching, or supervised exercise) on chemotherapy days. Use the app to log this activity and receive encouragement. Gradually increase duration and intensity as tolerated, working with your healthcare team.
  • Create a dashboard showing 4-week rolling averages of exercise consistency, mood trends, nutrition quality, and chemotherapy side effect severity. Share this data with your oncology team at each visit to identify patterns between lifestyle factors and treatment response. This personalized feedback loop helps optimize your intervention program.

This article describes a clinical trial protocol, not completed results. The predictions and expected benefits described are based on researchers’ hypotheses, not proven outcomes. This information is for educational purposes only and should not replace medical advice from your oncology team. Do not change your cancer treatment plan or start new exercise or nutrition programs without discussing them with your doctor first. If you are interested in participating in the DIANA trial or similar studies, speak with your healthcare provider about eligibility and enrollment options. Always follow your oncologist’s recommendations for cancer treatment.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Multimodal lifestyle intervention during neoadjuvant chemotherapy in patients with early breast cancer as a strategy to improve treatment response: Protocol of the DIANA randomized clinical trial. , PloS one (2026). PubMed 42945273 | DOI
Topics
breast cancer chemotherapy exercise during cancer treatment cancer prehabilitation neoadjuvant chemotherapy lifestyle intervention cancer cancer treatment response psychological support cancer nutrition counseling breast cancer